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Abstract The objective of the study is to assess the
effects of emphysema on peak oxygen uptake ( _VO2peak)
during a cardiopulmonary exercise test in patients with
chronic obstructive pulmonary disease (COPD). We mea-
sured _VO2peak and oxygen pulse in 80 patients with stable
COPD exercising maximally. Oxygen saturation was
measured by pulse oximetry (SpO2), and the ventilatory
response assessed by the ratio of tidal volume (VT) at peak
to slow vital capacity (SVC) at baseline, and by the percent
increase of peak VT over baseline. Computed tomography
imaging (CT scan) served as the reference diagnostic
standard for emphysema. Based on the panel-grading (PG)
method, emphysema was rated absent or mild (PG B 30,
n = 54), or moderate to severe (PG [ 30, n = 26).
Multiple quantile regression was applied to estimate the
effects of PG [ 30 on _VO2peak. At peak exercise, the
patients with PG [ 30 had significantly lower _VO2, oxygen
pulse and SpO2, and featured a blunted ventilatory
response with respect to those with PG B 30 (p \ 0.001).
With multiple quantile regression, the effects of PG [ 30
on _VO2Peak were only partially explained by the degree of
lung hyperinflation, a substantial component being imput-
able to impairment of lung diffusing capacity. In conclu-
sion, chronic obstructive pulmonary disease patients with
moderate to severe emphysema feature significantly lower
exercise tolerance than those with no or mild emphysema.
Our findings underscore the need of tailoring therapeutic
interventions for COPD to the predominant clinical phe-
notype to improve exercise capacity.
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Introduction
Chronic obstructive pulmonary disease (COPD) is char-
acterized by airflow limitation that is not fully reversible
[1]. Airflow obstruction results from the combination of
two mechanisms: increased airway resistance due to nar-
rowing of the small airways, and loss of lung elastic recoil
due to emphysema.
Over the years, evidence has emerged that patients with
COPD and predominant emphysema differ remarkably
from those with predominant airway disease [2–6].
A recent study, comprising 458 patients with established
COPD, shows that patients with radiologic evidence of
emphysema feature significantly lower body mass index,
greater airflow obstruction, and more severe impairment of
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lung diffusing capacity than those without emphysema [5].
In addition, emphysemic patients were found to have
greater restriction of physical activity and worse quality of
life than non-emphysemic ones [5]. The latter findings
were based on the results of a self-administered respiratory
questionnaire [7].
The present study was undertaken to assess the effects of
emphysema on peak oxygen uptake during a cardiopul-
monary exercise test in patients with stable COPD. Volu-
metric CT scan was used as the reference standard for
evaluating the presence and severity of emphysema.
Methods
Sample
The study sample comprises 80 consecutive patients with a
diagnosis of COPD based on a post-bronchodilatator ratio
of forced expiratory volume in 1 s to forced vital capacity
(FEV1/FVC) \ 0.70. All the patients were evaluated at the
outpatient clinic, Tuscany Foundation ‘‘G. Monasterio’’,
Pisa (Italy), between January 2008 and 2009.
Exclusion criteria were history of asthma, acute exac-
erbation of COPD in the 2 months preceding the study,
unstable angina, recent myocardial infarction or stroke,
heart failure (left ventricle ejection fraction \50% on
echocardiography), respiratory failure, poorly controlled
systemic arterial hypertension or cardiac dysrhythmia,
peripheral arteriopathy, or mental impairment precluding
cooperation.
In all the patients, we obtained pulmonary function tests
at baseline, including slow and forced expiratory flow rates
and volumes, intrathoracic gas volume by body plethys-
mography, single breath-diffusing capacity of the lung for
carbon monoxide (DLCO), and partial pressure of oxygen
(PaO2) and carbon dioxide (PaCO2) in arterial blood.
Spirometry, lung volumes and DLCO measurements were
performed according to ATS/ERS standards [8–10]. Blood
gases were measured while the patients were breathing
room air. Lung function tests were obtained on the same
day as the cardiopulmonary exercise test.
At the time of the study, all the patients were receiving
at least one of the following drugs: inhaled long-acting
beta-2-agonists (LABA, n = 68), inhaled long-acting
muscarinic antagonists (LAMA, n = 43), inhaled cortico-
steroids (ICS, n = 68), or oral theophylline (n = 11). For
further details, see the online data supplement. The therapy
had been prescribed by the attending physicians, and was
not discontinued prior to entering the study. None of the
patients had undergone any pulmonary rehabilitation pro-
gram, and none were on long-term oxygen therapy.
The protocol was approved by the institutional ethics
committee, and an informed written consent was obtained
from all the patients before entering the study.
Cardiopulmonary exercise test
The cardiopulmonary exercise test (CPET) was performed
on an electrically braked cycle ergometer (VO2max Encore
CPX, SensorMedics, CA) according to the ATS/ACCP
recommendations [11]. The protocol included three stages:
resting, unloaded pedaling, and exercise. The external work
rate was incremented continuously using the ramp protocol
(rate of increment 10 W/min). The patients were encour-
aged to cycle until exhaustion. During the test, the elec-
trocardiogram was monitored by telemetry, and the arterial
oxygen saturation measured by pulse oximetry (SpO2).
The slope of the rate of change in oxygen uptake divided
by the rate of change in external work (D _VO2=Dwork) was
taken as an index of the aerobic work efficiency. Peak
oxygen uptake ( _VO2peak) and ‘‘oxygen pulse’’, or the ratio
of _VO2 to the heart rate at peak exercise, were expressed as
percent of their predicted value using appropriate reference
equations [12].
The ventilatory response was assessed by the ratio of VT
at peak exercise to slow vital capacity (SVC) at baseline,
and by the percent increase of VT over baseline, that is [(VT
at peak exercise - VT at baseline)/VT at baseline] 9 100.
The modified Borg scale was used to rate the intensity of
breathing discomfort and of leg discomfort at rest and at
peak exercise [13]. The patients were asked to specify the
reason(s) why they stopped exercising.
The test was interrupted if any of the following were
recorded: signs of ischemia on the electrocardiogram,
hypertension (systolic blood pressure [220 mmHg or
diastolic blood pressure [120 mmHg), second or third
degree heart block, or severe desaturation (SpO2 B 80%).
Computed tomography
Volumetric CT scan of the thorax was obtained within
2 weeks of CPET. It was performed on a 64-detector row
scanner (Toshiba Aquilion, Japan) with the patient breath
holding at full inspiration for 10 s. No contrast medium
was infused. Acquisition setting was 120 kVp with mAs
modulated according to the patient’s attenuation as asses-
sed before scan acquisition (range 60–250 mAs). Slice
thickness was set at 0.65 mm. Scans were reconstructed in
the axial, sagittal and coronal planes. Images were viewed
using a window level of -600 Hounsfield Units (HU) and a
width of 1,500 HU, and were examined independently by a
chest radiologist and a chest physician for the presence of
areas of low attenuation and vascular disruption. Both
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raters were blinded to lung function and CPET data.
Maximum intensity projection technique was used to
evaluate vascular disruption, and minimum intensity pro-
jection to highlight focal areas of low attenuation in the
lung parenchyma [14].
The severity of emphysema was scored on a non-para-
metric scale from 0 (no emphysema) to 100 using the
panel-grading (PG) method of Thurlbeck et al. [15].
This consists of 16 inflation-fixed, paper-mounted,
midsagittal whole lung sections that are arranged at inter-
vals of 5 between 0 and 50, and at intervals of 10 between
60 and 100. A PG of 5 or less is consistent with trace
emphysema, a PG of 10–30 indicates mild emphysema, a
PG [ 30 to 50 moderate emphysema, and a PG [ 50 to
100 severe emphysema. In scoring emphysema on CT, the
two raters used sagittal lung sections and gave them the PG
of the standard most closely similar, or a PG between two
standards.
Statistical analysis
For the categorical variables, differences between emphy-
semic and non-emphysemic patients were tested for by
Fisher’s exact test. For the continuous variables, Mood’s
median test was used, and the exact p value reported.
Continuous variables are reported in the text and tables as
median and interquartile range (IQR).
The scatter plot of the PG of emphysema by the two
independent raters was tested for departure from perfect
agreement by fitting a simple linear regression model and
testing the null hypothesis that the intercept is equal to zero
and the slope is equal to one, jointly. The resulting p value
was 0.329, thus indicating no statistically significant dif-
ference in scoring emphysema. Therefore, the PG scores by
the two independent raters were averaged. Multiple quan-
tile regression was applied to estimate the effect of
emphysema on the 25th, median, and 75th percentile of
_VO2peak during CPET. The dependent variable _VO2peak was
expressed as percentage predicted. The independent vari-
ables were emphysema (absent or mild, PG B 30 and
moderate to severe, PG [ 30), gender, ratio of inspiratory
capacity to total lung capacity (IC/TCL), and DLCO as
percentage predicted. In the text and tables, we give the
estimates, 95% confidence intervals, and p values for dif-
ferent sets of independent variables. With 5,000 bootstrap
replicates, we estimated a 96.6% power to detect the
observed difference in median _VO2peak between the COPD
patients with moderate to severe emphysema and those
with no or only mild emphysema. Two-tailed p values of
less than 0.05 were considered statistically significant
throughout.
Results
Emphysema was diagnosed consistently by the two inde-
pendent raters in 34 (43%) of 80 patients. The two raters
assigned the same PG in 62 cases of whom 46 were con-
sidered as not having emphysema (PG = 0). Among the
emphysemic patients, the median PG was 45 (IQR 35–60).
Eight patients had mild emphysema (PG between 5 and
30), either paraseptal or centrilobular, predominantly dis-
tributed in the upper lobes; they did not differ from the
46 patients without emphysema as regards age, gender,
cumulative smoking history, or baseline lung function.
We therefore divided the study sample in two groups as
follows: (a) no or mild emphysema (PG B 30, n = 54), (b)
moderate to severe emphysema (PG [ 30, n = 26).
The patients with PG [ 30 had significantly lower BMI,
FEV1, IC/TCL ratio, and DLCO than those with PG B 30
(Table 1). There was no significant difference across the
two groups with regard to age, gender, pack-years of
smoking, or resting arterial blood gases (Table 1).
Most (88%) of the patients with PG [ 30 stopped
exercising because of severe breathing discomfort, either
alone or in combination with leg discomfort (Table 2) and
such limitation occurred in 63% of the patients with
PG B 30.
Figure 1 shows the frequency distribution of structural
emphysema in the study sample as a function of the
maximum work load attained. The proportion of patients
with PG [ 30 was significantly higher in the lower tertile
than in the mid or upper tertile of the maximum work load.
The crude difference in the median value of maximum
work load between the patients with PG [ 30 and those
with PG B 30 was -20 W (Table 2). After adjusting for
age and gender, the difference was -29.44 W. Both dif-
ferences were highly statistically significant (p \ 0.001).
At peak exercise, the patients with PG [ 30 had sig-
nificantly lower _VO2, oxygen pulse, and SpO2 than those
with PG B 30; also, they featured a blunted ventilatory
response as reflected by the lower VT peak/SVC ratio, and
the smaller percent increase of peak VT over baseline
(Table 2). There was no significant difference between the
two groups with regard to aerobic work efficiency
(Table 2).
Among the patients with PG [ 30, _VO2peak was signif-
icantly correlated with DLCO, IC/TLC ratio, FEV1 and, to a
smaller extent, with BMI (Table 3). In the patients with
PG B 30, _VO2peak correlated significantly with DLCO and
IC/TLC, but not with FEV1 or BMI (Table 3). In both
groups, there was a highly significant linear correlation
between _VO2peak and the ventilatory response at peak
exercise (Table 3).
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Figure 2 shows the effects of PG [ 30 on the median
value of _VO2peak as estimated with multiple quantile
regression.
The crude effect is estimated to be -21. This means that
the median _VO2peak is smaller in the patients with PG [ 30
than in the others by 21 percentage points (p \ 0.001).
After adjusting by gender, the difference is only slightly
reduced. After further adjusting for IC/TLC ratio, the dif-
ference drops somewhat, but remains statistically signifi-
cant (p = 0.002). This means that there is an effect of
PG [ 30 on median _VO2peak, which is independent of the
degree of hyperinflation at rest as reflected by IC/TLC
ratio. Finally, when we further adjust for DLCO as per-
centage predicted, the difference nearly vanishes, and is no
longer statistically significant (p = 0.889).
The interpretation of the effects of PG [ 30 on the other
quartiles of _VO2peak is analogous. However, the effects are
larger on the median than on the first quartile, and even
larger on the third quartile (see the online data supple-
ment). This is the consequence of the distribution of
_VO2peak values that is more spread in the patients with
PG B 30 than in those with PG [ 30 (Fig. 3).
Table 1 Baseline characteristics of the study sample
Characteristic All patients
(n = 80)
No or mild
emphysema (n = 54)
Moderate to severe
emphysema (n = 26)
p*
Age (years) 70 (64–73) 68 (64–72) 71 (67–75) 0.811
Male sex 62 (78) 41 (76) 21 (81) 0.777
BMI (kg/m2) 27 (24–31) 28 (26–31) 24 (22–26) 0.003
Current smokers 14 (18) 11 (20) 3 (12) 0.531
Pack-years of smoking 41 (30–52) 40 (27–50) 45 (37–53) 0.322
FEV1 (% predicted) 57 (40–71) 65 (54–77) 38 (34–54) \0.001
IC/TLC (%) 39 (31–45) 43 (36–46) 29 (25–34) \0.001
DLCO (% predicted) 74 (63–88) 81 (72–97) 51 (41–67) \0.001
Resting PaO2 (mmHg) 75 (70–81) 77 (72–81) 71 (66–82) 0.470
Resting PaCO2 (mmHg) 38 (36–40) 38 (35–40) 39 (37–41) 0.054
Data are reported as median (interquartile range), or number (%)
BMI body mass index, FEV1 forced expiratory volume in one second, IC inspiratory capacity, TLC total lung capacity, DLCO diffusing capacity
of the lung for carbon monoxide, PaO2 partial pressure of oxygen in arterial blood, PaCO2 partial pressure of carbon dioxide in arterial blood
* No or mild versus moderate to severe emphysema
Table 2 Cardiopulmonary exercise test in COPD patients
Measured variable All patients
(n = 80)
No or mild emphysema
(n = 54)
Moderate to severe
emphysema (n = 26)
p*
Breathing discomfort (Borg scale) 57 (71) 34 (63) 23 (88) 0.019
Maximum work load (W) 70 (60–90) 80 (70–108) 60 (46–70) \0.001
D _VO2=Dwork (mL/min/W) 12 (11–14) 12 (11–14) 12 (11–14) 0.346
Heart rate at peak (cycles/min) 119 (108–130) 119 (111–133) 114 (105–123) 0.235
Respiratory rate at peak (cycles/min) 30 (26–33) 30 (27–33) 31 (26–35) 0.814
_VO2peak (mL/min/kg) 12 (10–15) 13 (11–16) 10 (9–11) \0.001
_VO2peak (% predicted) 49 (37–62) 55 (46–67) 34 (29–44) \0.001
Oxygen pulse at peak (% predicted) 63 (49–78) 71 (59–81) 44 (40–62) \0.001
SpO2 at peak (%) 95 (92–96) 96 (94–97) 91 (89–94) \0.001
VT at peak/SVC (%) 43 (36–48) 45 (40–50) 35 (32–41) \0.001
Increase of peak VT over baseline (%) 125 (72–156) 133 (103–174) 75 (56–91) \0.001
Data are reported as median (interquartile range), or number (%)
D rate of change, _VO2peak oxygen uptake at peak exercise, oxygen pulse _VO2=heart rate at peak exercise, SpO2 arterial oxygen saturation by
pulse oximeter, VT tidal volume, SVC slow vital capacity at baseline, increase in VT over baseline = [(VT at peak - VT at baseline)/VT at
baseline] 9 100
* No or mild versus moderate to severe emphysema
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Discussion
Our results can be summarized as follows: (a) patients with
COPD and moderate to severe emphysema on CT have
significantly greater impairment of baseline lung function
than those with no, or only mild emphysema; (b) upon
exercising maximally, emphysemic patients feature sig-
nificantly lower _VO2peak, oxygen pulse and SpO2, and
exhibit a blunted ventilatory response with respect to non-
emphysemic ones; (c) lung hyperinflation and impaired
diffusing capacity contribute to exercise intolerance in
patients with overt emphysema.
As to the mechanisms underlying the reduced exercise
tolerance in COPD, Diaz et al. [16] find a significant linear
correlation between baseline IC (as percentage predicted)
and _VO2peak (r = 0.750, p \ 0.001). In stepwise multiple
regression, IC and FEV1/FVC ratio are the only significant
contributors to the reduced exercise tolerance [16]. In that
study, however, neither the lung diffusing capacity, nor the
presence and severity of structural emphysema were
assessed.
O’Donnell et al. [17] report that COPD patients fail to
expand VT in response to the increased metabolic demand
imposed by maximal exercise. _VO2peak best correlates with
Fig. 1 Frequency distribution of structural emphysema as a function
of the maximum work load (tertiles) in 80 patients with COPD. Black
bars moderate to severe emphysema (PG [ 30). Gray bars no or only
mild emphysema (PG B 30). The proportion of patients with
PG [ 30 is significantly higher in the lower tertile than in the mid,
or upper tertile (p = 0.002 and p \ 0.001, respectively)
Table 3 Correlations with peak oxygen uptake during cardiopulmonary exercise test in COPD
Independent variable All patients (n = 80) No or mild emphysema (n = 54) Moderate to severe emphysema (n = 26)
r p r p r p
BMI (kg/m2) 0.374 \0.001 0.125 0.368 0.471 0.015
FEV1 (% predicted) 0.403 \0.001 0.058 0.677 0.653 \0.001
IC/TLC (%) 0.608 \0.001 0.366 0.006 0.728 \0.001
DLCO (% predicted) 0.642 \0.001 0.516 \0.001 0.628 \0.001
Resting PaO2 (mmHg) 0.223 0.046 0.114 0.412 0.203 0.320
Resting PaCO2 (mmHg) -0.049 0.666 0.177 0.200 -0.231 0.256
VT at peak/SVC (%) 0.619 \0.001 0.485 \0.001 0.554 0.003
Increase of peak-VT over baseline (%) 0.657 \0.001 0.543 \0.001 0.578 0.002
SpO2 at peak (%) 0.281 0.012 -0.151 0.276 0.204 0.318
r = Pearson’s correlation coefficient
For abbreviations, see Tables 1 and 2
Fig. 2 Difference in median oxygen uptake at peak exercise
( _VO2peak) between COPD patients with moderate to severe emphy-
sema (PG [ 30), and those with no or only mild emphysema
(PG B 30). a Unadjusted difference (p \ 0.001). b Adjusted for
gender (p \ 0.001). c Adjusted for gender, and IC/TLC ratio
(p = 0.002). d Adjusted for gender, IC/TLC ratio, and DLCO as
percentage predicted (p = 0.889). Dashed lines identify the 95%
confidence interval of the difference in median _VO2peak
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peak VT (r = 0.682), resting IC (r = 0.451), and DLCO
(r = 0.437). Curtailment of VT response to exercise is
ascribed primarily to dynamic hyperinflation, but no rela-
tionship is established between changes in peak VT and
severity of structural emphysema as reflected by radiologic
imaging [17].
In our study, peak VT increased by a median value of
133% over baseline in the patients with no or mild
emphysema as opposed to only 75% in those with mod-
erate to severe emphysema.
With multiple quantile regression, we find that the
effects of moderate to severe emphysema on the three
quartiles of _VO2peak are only partially explained by the
degree of lung hyperinflation (IC/TLC ratio), a substantial
component being imputable to the impaired lung diffusing
capacity.
In normal subjects, the diffusing capacity of the lung
increases during exercise mainly because of an increase in
pulmonary capillary blood volume [18]. In emphysemic
patients, the pulmonary capillary blood volume is dimin-
ished to a variable extent due to the loss of alveoli and
alveolar capillaries [19]. Therefore, it is physiologically
plausible that the impairment of lung diffusing capacity
contributes substantially in limiting exercise capacity in the
patients with moderate to severe emphysema.
Despite this, our findings indicate that the degree of lung
hyperinflation also contributes in reducing exercise toler-
ance in COPD patients, as suggested by other investigators
[16, 17].
Vassaux et al. [20] measured oxygen pulse at rest and at
peak exercise in 87 patients with severe or very severe
COPD, and in 46 age- and sex-matched controls. They find
that patients with very severe hyperinflation at rest
(IC/TLC B 25%) have significantly lower peak oxygen
pulse than both patients with IC/TLC [ 25% and controls.
The authors conclude that reduced cardiac performance,
as reflected by the lower oxygen pulse, contributes to
exercise limitation in severely hyperinflated COPD
patients. In that study, however, the severity of emphysema
was not established because there was no radiologic
assessment [20].
Jo¨rgensen et al. [21] measured intrathoracic blood vol-
ume, and left and right ventricular dimensions by magnetic
resonance imaging in 13 patients with very severe
emphysema and 11 healthy volunteers.
They observe that intrathoracic blood volume is signif-
icantly reduced in emphysemic patients when compared
with normal subjects, and so are the end-diastolic ven-
tricular volume index, and stroke volume index. The
authors reason that the decreased biventricular preload in
emphysemic patients might be due to intrathoracic hypo-
volemia brought about by severe lung hyperinflation [21].
In our study, peak oxygen pulse is significantly lower in
the patients with moderate to severe emphysema than in
those with no or mild emphysema.
The use of oxygen pulse as an index of stroke volume
requires the assumption that the arterial-mixed venous
oxygen difference be maximal and constant [11]. This may
not be true in the patients, who desaturate during exercise
[11]. Because we did not measure the arterial-mixed
venous oxygen gradient, we felt it inappropriate to use
peak oxygen pulse as a surrogate of cardiac performance.
Nevertheless, we do not exclude the possibility that cardiac
dysfunction may contribute to limit exercise tolerance in
COPD patients with very severe emphysema.
In summary, we find that patients with COPD and
moderate to severe emphysema feature significantly lower
exercise tolerance than those with no or mild emphysema.
This may be somewhat expected because the patients with
overt emphysema have greater impairment of baseline lung
function than the others. Yet, it seems to have little impact
on the behavior of the practicing physicians. In fact, the
patients reported on here were all uniformly treated by their
physicians with inhaled bronchodilators and inhaled corti-
costeroids according to the guidelines on COPD manage-
ment [1]. Nearly 70% of the emphysemic patients were on
triple therapy including LABA, LAMA, and ICS (see
online data supplement). In these patients, such ‘‘standard’’
treatment appears ineffective in improving exercise
tolerance.
Our data underscore the need for the tailoring of ther-
apeutic interventions for COPD to the predominant clinical
phenotype to improve exercise tolerance and quality of life.
In particular, we believe that randomized trials are war-
ranted to establish whether pulmonary rehabilitation pro-
grams are more effective than standard pharmacological
Fig. 3 Box and whisker plot of oxygen uptake at peak exercise
( _VO2peak) in COPD patients as a function of the presence and severity
of emphysema on computed tomography (CT). Line in box median.
Box height interquartile range. Whiskers extreme values. p \ 0.001
by Mood’s median test
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therapy in COPD patients with a predominant emphysema
phenotype.
In the present study, volumetric CT of the thorax was
used as the reference standard for diagnosing emphysema.
In our experience, digital chest radiography is a valuable
alternative to the CT scan in routine clinical practice,
provided that explicit diagnostic criteria are used [5].
Recently, a neural network-based, computer-aided
method was introduced that allows online recognition of
emphysema on digital chest radiographs [22]. This method,
validated against CT, might be used advantageously by
clinicians because it is simple and inexpensive. Its appli-
cation may reduce the costs of the diagnostic procedures
for emphysema, and minimize the radiation burden to the
patient.
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